Targeting the N otch pathway: A potential therapeutic approach for desmoid tumors-Reference-Cited by-同舟云学术

Targeting the N otch pathway: A potential therapeutic approach for desmoid tumors

Published:2015-09-08 Issue:22 Volume:121 Page:4088-4096
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Shang Hui¹²,Braggio Danielle¹³⁴,Lee Ya‐Jung¹,Al Sannaa Ghadah A.⁵,Creighton Chad J.⁶,Bolshakov Svetlana¹,Lazar Alexander J. F.¹⁵⁷,Lev Dina⁸,Pollock Raphael E.¹³⁷

Affiliation:

1. Department of Surgical OncologyThe University of Texas MD Anderson Cancer CenterHouston Texas

2. Department of OrthopedicsTaihe Hospital, Hubei University of MedicineShiyan China

3. Department of Surgical OncologyComprehensive Cancer Center, Ohio State UniversityColumbus Ohio

4. Department of Investigative PathologyInternational Center for Research, A. C. Camargo Cancer CenterSão Paulo Brazil

5. Department of PathologyThe University of Texas MD Anderson Cancer CenterHouston Texas

6. Dan L. Duncan Cancer CenterBaylor College of MedicineHouston Texas

7. Sarcoma Research Center, The University of Texas MD Anderson Cancer CenterHouston Texas

8. Surgery B, Sheba Medical CenterTel Aviv Israel

Funder

Desmoid Tumor Research Foundation

Pfizer

National Cancer Institute of the National Institutes of Health

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.29564

Reference40 articles.

1. Aggressive Fibromatosis (Desmoid Tumor) is A Monoclonal Disorder

2. Specific Mutations in the β-Catenin Gene (CTNNB1) Correlate with Local Recurrence in Sporadic Desmoid Tumors

3. APC mutations in FAP-associated desmoid tumours are non-random but not ‘just right’

4. Response of extraabdominal desmoid tumors to therapy with imatinib mesylate

5. Optimizing Treatment of Desmoid Tumors

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gamma-Secretase Inhibitors Downregulate the Profibrotic NOTCH Signaling Pathway in Recessive Dystrophic Epidermolysis Bullosa;Journal of Investigative Dermatology;2024-07

2. Resistance to PSEN1-selective γ-secretase inhibitors in T-cell acute lymphoblastic leukemia;2024-03-06

3. Nirogacestat: First Approval;Drugs;2024-02-27

4. Desmoid-type fibromatosis: Current therapeutic strategies and future perspectives;Cancer Treatment Reviews;2024-02

5. Desmoid Tumors: Current Perspective and Treatment;Current Treatment Options in Oncology;2024-01-25